These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25921929)

  • 1. Angiotensin-dependent autonomic dysregulation precedes dilated cardiomyopathy in a mouse model of muscular dystrophy.
    Sabharwal R; Weiss RM; Zimmerman K; Domenig O; Cicha MZ; Chapleau MW
    Exp Physiol; 2015 Jul; 100(7):776-95. PubMed ID: 25921929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.
    Sabharwal R; Chapleau MW
    Exp Physiol; 2014 Apr; 99(4):627-31. PubMed ID: 24334334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.
    Sabharwal R; Cicha MZ; Sinisterra RD; De Sousa FB; Santos RA; Chapleau MW
    Clin Sci (Lond); 2014 Jul; 127(2):101-9. PubMed ID: 24502705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy.
    Bauer R; Macgowan GA; Blain A; Bushby K; Straub V
    Cardiovasc Res; 2008 Sep; 79(4):652-61. PubMed ID: 18495669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.
    Quattrocelli M; Crippa S; Montecchiani C; Camps J; Cornaglia AI; Boldrin L; Morgan J; Calligaro A; Casasco A; Orlacchio A; Gijsbers R; D'Hooge J; Toelen J; Janssens S; Sampaolesi M
    J Am Heart Assoc; 2013 Aug; 2(4):e000284. PubMed ID: 23963759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) mice.
    Bauer R; Enns H; Jungmann A; Leuchs B; Volz C; Schinkel S; Koch WJ; Raake PW; Most P; Katus HA; Müller OJ
    Neuromuscul Disord; 2019 Mar; 29(3):231-241. PubMed ID: 30782477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy.
    Greally E; Davison BJ; Blain A; Laval S; Blamire A; Straub V; MacGowan GA
    J Cardiovasc Magn Reson; 2013 Jan; 15(1):4. PubMed ID: 23324314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy.
    Goldstein JA; Kelly SM; LoPresti PP; Heydemann A; Earley JU; Ferguson EL; Wolf MJ; McNally EM
    Hum Mol Genet; 2011 Mar; 20(5):894-904. PubMed ID: 21138941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress.
    Wilkinson R; Song W; Smoktunowicz N; Marston S
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1936-46. PubMed ID: 26432839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.
    Bauer R; Blain A; Greally E; Bushby K; Lochmüller H; Laval S; Straub V; MacGowan GA
    Eur J Heart Fail; 2010 Nov; 12(11):1163-70. PubMed ID: 20675662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.
    Goehringer C; Rutschow D; Bauer R; Schinkel S; Weichenhan D; Bekeredjian R; Straub V; Kleinschmidt JA; Katus HA; Müller OJ
    Cardiovasc Res; 2009 Jun; 82(3):404-10. PubMed ID: 19218289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models.
    Iwata Y; Wakabayashi S; Ito S; Kitakaze M
    Lab Invest; 2020 Feb; 100(2):324-337. PubMed ID: 31896817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy.
    Blain A; Greally E; Laval S; Blamire A; Straub V; MacGowan GA
    PLoS One; 2013; 8(2):e57260. PubMed ID: 23437355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Tonic Contraction as a Novel Biomarker of Cardiomyopathy in Duchenne Muscular Dystrophy.
    Su JA; Ramos-Platt L; Menteer J
    Pediatr Cardiol; 2016 Apr; 37(4):678-85. PubMed ID: 26714815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential histological features and myogenic protein levels in distinct muscles of d-sarcoglycan null muscular dystrophy mouse model.
    Palma-Flores C; Cano-Martínez LJ; Fernández-Valverde F; Torres-Pérez I; de Los Santos S; Hernández-Hernández JM; Hernández-Herrera AF; García S; Canto P; Zentella-Dehesa A; Coral-Vázquez RM
    J Mol Histol; 2023 Aug; 54(4):405-413. PubMed ID: 37358754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.
    Coral-Vazquez R; Cohn RD; Moore SA; Hill JA; Weiss RM; Davisson RL; Straub V; Barresi R; Bansal D; Hrstka RF; Williamson R; Campbell KP
    Cell; 1999 Aug; 98(4):465-74. PubMed ID: 10481911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy.
    Tripathi R; Sullivan R; Fan TM; Wang D; Sun Y; Reed GL; Gladysheva IP
    PLoS One; 2017; 12(12):e0189315. PubMed ID: 29240788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.